Primary prevention of cardiovascular diseases among women in a South Asian population: a descriptive study of modifiable risk factors.
Rubina Rauf, Muhammad Nauman Khan, Jawaid Akbar Sial...
https://pubmed.ncbi.nlm.nih.gov/39542488/Actively Recruiting
Led by National Institute of Cardiovascular Diseases, Pakistan · Updated on 2026-04-13
10000
Participants Needed
1
Research Sites
521 weeks
Total Duration
Researchers are observing patients at preventive cardiology clinics to better understand how cardiovascular risk assessment tools can be used most effectively. The study aims to explore how these tools influence the risk of cardiovascular disease CVD and related outcomes, focusing on both primary and secondary prevention. This ongoing research collects data to help clinicians develop personalized, effective treatment plans by combining individual risk factors. The study involves adult patients attending the National Institute of Cardiovascular Diseases NICVD in Karachi, Pakistan. It gathers detailed information such as demographic data, physical exams, clinical history, risk modifications, laboratory tests, and risk scores like the ASCVD and WHO Cardiovascular Risk scores. These assessments are recorded at the first visit and during follow-ups to track changes over time. Participants provide verbal consent and are followed over a long period, with data collection continuing regularly. Researchers analyze this information to measure cardiovascular risk over ten years, changes in risk levels, and cardiovascular-related deaths. The study uses structured questionnaires and statistical methods to evaluate the findings, aiming to contribute valuable insights into cardiovascular disease prevention and management.
CONDITIONS
A Hospital-Based Registry of Preventive Cardiology Clinics
D
Dr Rubina Rauf
M
Musa Karim
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Institute of Cardiovascular Diseases, Pakistan
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 10 years
Participants who undergo routine care are observed with cardiovascular risk assessments at presentation and during follow-up visits.
Follow-up visits as scheduled by the preventive cardiology clinics
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Rubina Rauf, Muhammad Nauman Khan, Jawaid Akbar Sial...
https://pubmed.ncbi.nlm.nih.gov/39542488/National Institute of Cardiovascular Diseases, Pakistan
Lead Sponsor